Vacunas de COVID-19 Para Niños de 6 Meses a 5 Años Recibe Autorización Federal; Vacunas Desde de la Semana de Jun. 20

DOVER, DE (18 de Junio, 2022) – Los padres de niños de 6 meses a 5 años podrán vacunar a sus hijos contra el COVID-19 a partir de la semana del 20 de Junio de 2022, según la División de Salud Pública (DPH). Las vacunas para este grupo de edad más joven recibieron la aprobación final para la Autorización de Uso de Emergencia de la Administración de Alimentos y Medicamentos (FDA) el Viernes y los Centros para el Control y la Prevención de Enfermedades (CDC) hoy.

Tanto la vacuna de Moderna como la de Pfizer-BioNTech fueron autorizadas para este grupo de edad, con leves diferencias entre ambas. Moderna es una vacuna de una serie de dos dosis, que contiene una cuarta parte de la dosis para adultos, para niños de 6 meses a 5 años. La eficacia estimada varía según la edad. La vacuna de Pfizer es una serie primaria de tres dosis que es una décima parte de la dosis para adultos y está autorizada para niños de 6 meses a 4 años, ya que su vacuna para niños de 5 años ya está aprobada. Tiene una efectividad estimada del 80% después de la tercera dosis.

Los efectos secundarios fueron generalmente leves y no se identificaron efectos secundarios graves. Para Moderna, los efectos secundarios reportados con mayor frecuencia en todas las edades incluyeron dolor, enrojecimiento e hinchazón en el lugar de la inyección, fiebre e hinchazón/sensibilidad en las axilas en el lugar de la inyección. Los efectos secundarios de Pfizer incluyeron irritabilidad, disminución de apetito, fiebre, dolor de cabeza, escalofríos y dolor, sensibilidad, enrojecimiento e hinchazón en el lugar de la inyección.

DPH ha incluido una tabla conveniente en de.gov/youthvaccine que explica las diferencias entre las dos vacunas.

Los cargamentos iniciales de Pfizer y Moderna están programados para llegar a Delaware el lunes 20 de junio de 2022 y se enviarán a los proveedores médicos que ordenaron uno o ambos con anterioridad. No todos los proveedores pre-ordenaron la vacuna inicialmente. Aunque algunos proveedores pueden estar listos para comenzar a administrar tan pronto como el 21 de Junio de 2022, otros han indicado que comenzarán después. DPH recomienda encarecidamente que los padres se comuniquen con su proveedor de atención médica pediátrica para obtener detalles específicos sobre la programación y tiempo. Se alienta a los padres a visitar de.gov/youthvaccine para obtener una lista de proveedores que ofrecen vacunas. Los suministros y el acceso aumentarán a medida que avance la semana.

“Estamos increíblemente felices y con tranquilidad de que una vacuna COVID-19 ahora estará disponible para nuestra población más joven a partir de los 6 meses de edad,” dijo la Directora del DPH, la Dra. Karyl Rattay. “Reconocemos la preocupación que padres con niños pequeños han enfrentado esperando que la vacuna esté disponible mientras que buscan formas de proteger a los más pequeños de este virus. Esperamos que los padres consulten con el proveedor de su hijo o con el centro médico apropiado para determinar la mejor opción para ellos.”

Las vacunas estarán disponibles a través de pediatras/proveedores de atención primaria, clínicas DPH y Centros de Salud Calificados Federalmente. Además de las clínicas del DPH, algunos proveedores adicionales acordaron vacunar a los que no son pacientes. Esa información se agregará a de.gov/youthvaccine a medida que esté disponible.

Las farmacias también vacunarán a bebés y niños en este grupo de edad. Sin embargo, es importante que las familias sepan que no todos vacunarán a los niños menores de 3 años. Ubique las farmacias participantes en vaccines.gov. La base de datos agregó una función que permite que las farmacias ingresen la edad más baja en la que están dispuestas a vacunar y debería aparecer cuando los padres busquen una vacuna para este grupo de edad más joven.

Aunque niños y adolescentes suelen tener menos riesgo que los adultos de enfermarse gravemente o ser hospitalizados por COVID-19, durante el aumento de Omicron (Invierno de 2021-22), sus tasas de enfermedad aumentaron. Durante el aumento invernal de Omicron, los bebés y niños menores de 5 años fueron hospitalizados con el virus a una tasa aproximadamente cinco veces más alta que durante el aumento de Delta (otoño de 2021), según un hallazgo reciente de un estudio de los Centros para el Control y la Prevención de Enfermedades (CDC). Adicionalmente, los resultados graves de COVID-19 son impredecibles y pueden ocurrir en niños sanos. El riesgo es mayor en aquellos con condiciones de salud subyacentes. Según datos del CDC, el 64% de las hospitalizaciones en menores de 5 años se da en aquellos sin comorbilidades. Por último, el COVID-19 puede causar enfermedades adicionales a largo plazo en niños. Entre tres y seis por ciento de los niños con COVID-19 se reportan síntomas continuos durante más de 12 semanas.

Los padres o guardianes que tengan preguntas sobre qué vacuna es adecuada para su hijo deben consultar a su proveedor pediátrico o médico de familia/proveedor de atención médica. Se anticipa que la mayoría de los padres acudirán a proveedores pediátricos para vacunar a bebés y niños en este grupo de edad.


COVID-19 Vaccines For Children 6 Months to 5 Years Receives Federal Authorization; DE Vaccines to Begin Week of June 20

DOVER, DE (June 18, 2022) – Parents of children ages 6 months through 5 years old, will be able to get their children vaccinated against COVID-19 starting the week of June 20, 2022, according to the Division of Public Health (DPH). Vaccines for this youngest age group received final sign off for Emergency Use Authorization, from the Food and Drug Administration (FDA) Friday, and the Centers for Disease Control and Prevention (CDC) today.

Both Moderna and Pfizer-BioNTech vaccines were authorized for this age group, with slight differences between the two. Moderna’s is a two-dose series of vaccine, which is one-quarter the adult dosage, for children ages 6 months through 5 years old.  Estimated effectiveness varies based on age. The Pfizer vaccine is a three-dose primary series that is one-tenth the adult dosage and is authorized for children 6 months through 4 years old, as their vaccine for 5-year-olds is already approved. It has an estimated effectiveness of 80% after the third dose.

Side effects were generally mild, and no serious side effects were identified. For Moderna, the most commonly reported side effects across all ages included pain, redness and swelling at the injection site, fever and underarm swelling/tenderness at the injection site. For Pfizer side effects included irritability, decreased appetite, fever, headache, chills and pain, tenderness, redness and swelling at the injection site.

DPH has included a convenient chart on de.gov/youthvaccine explaining the differences between the two vaccines.

Initial shipments of Pfizer and Moderna are set to arrive in Delaware on Monday, June 20, 2022, and are going to medical providers who pre-ordered either one, or both of them. Not all providers pre-ordered vaccine initially. While some providers may be ready to start administering as soon as June 21, 2022, others have indicated they will begin later. DPH strongly recommends that parents contact their pediatric health care provider for specifics on scheduling and timing.  Parents are encouraged to visit de.gov/youthvaccine for a list of providers offering vaccines. Supply and access will increase as the week goes on.

“We are incredibly happy and relieved that a COVID-19 vaccine will now be available to our youngest population starting at 6 months old,” said DPH Director Dr. Karyl Rattay.  “We recognize the concern that parents with young children have faced waiting for the vaccine to become available as they look for ways to protect their youngest from this virus.  It is our hope that parents will consult with their child’s provider or the appropriate medical facility to determine the best option for them.”

Vaccines will be available from pediatricians/primary care providers, DPH clinics, and Federally Qualified Health Centers. In addition to DPH clinics, a few additional providers have agreed to vaccinate non-patients. That information will be added to de.gov/youthvaccine as it becomes available.

Pharmacies will also vaccinate infants and children in this age group. However, it is important for families to know that not all will vaccinate children under age 3. Locate participating pharmacies at vaccines.gov. The database has added a feature which allows pharmacies to enter the lowest age they are willing to vaccinate and should show up when parents search for a vaccine for this youngest age group.

While children and adolescents are typically at lower risk than adults of becoming severely ill or hospitalized from COVID-19, during the Omicron surge (Winter 2021-22), their rates of illness increased. During the winter Omicron surge, infants and children under 5 years of age were hospitalized with the virus at approximately five times the rate they were during the Delta surge (Fall 2021), a study from the Centers for Disease Control and Prevention (CDC) recently found. Additionally, severe COVID-19 outcomes are unpredictable and can occur in healthy children. The risk is higher in those with underlying health conditions.  According to data from the CDC, 64% of hospitalizations in children under 5 years occur in those without comorbidities. Lastly, COVID-19 can cause additional long-term illness in children. Between three and six percent of children with COVID-19 report continued symptoms for more than 12 weeks.

Parents or guardians with questions about which vaccine is right for their child should consult their pediatric provider or family doctor/health care provider. It is anticipated that most parents will turn to pediatric providers to vaccinate infants and children in this age group.


Dr. Karyl Rattay Announces Departure From Delaware Division Of Public Health Effective June 30, 2022

DOVER, DE (MAY 13, 2022) – Today, Dr. Karyl Rattay is announcing that she will be leaving her role as Director of the Delaware Division of Public Health (DPH) effective June 30, 2022.  Dr. Rattay assumed her position in 2009, during the H1N1 influenza pandemic, and is the nation’s longest serving Public Health Director.

As Delaware’s State Health Official, Dr. Rattay leads nearly 1,000 employees who promote health, reduce health inequities, and protect Delawareans from disease, environmental hazards, and public health emergencies.

“It has been the greatest honor of my lifetime to serve Delawareans in this role, said Dr. Rattay. “I am grateful for the opportunity to have served under Governor Carney, and Governor Markell before him.  I could not be prouder of the DPH team and what we have accomplished together over the past 13 years.”

“When you work with someone through a crisis, you really see what they’re made of. Dr. Rattay is smart, steady, focused, and committed,” said Governor John Carney. Most importantly though, she is kind and compassionate. Her style of leadership and her work ethic are what helped Delaware make it through this pandemic. And the work Dr. Rattay did at Public Health in the decade leading up to the pandemic is why her team was ready and able to step up and manage this crisis. We will miss Dr. Rattay as a member of our team and I am personally grateful to her for all she did to lead us through this once-in-a-generation public health crisis.”

“In her 13 years as our Director of the Division of Public Health, Dr. Karyl Rattay has been driven by a singular focus: How could she and her team improve and protect the health and well-being of the Delawareans they serve,” said Department of Health and Social Services (DHSS) Secretary Molly Magarik. “Her values, her work ethic and her passion for this work have never wavered. She believes in meeting communities where they are, listening to stakeholders across the spectrum, and building public health responses that are tailored to the populations we are serving. On behalf of the employees of DHSS and the people of Delaware, I offer my heartfelt gratitude to Dr. Rattay her leadership, her innovative spirit, and her commitment to our state.”

Dr. Rattay says leading the state through the COVID-19 pandemic over the last two years – the greatest public health crisis in a century – has tested those in public health departments professionally and personally. She indicated that while she is not ready to announce her next role, she is excited about the new opportunities in front of her and believes this is a good time to transition the Division to its next leader.  

During her tenure at DPH Dr. Rattay and her team have:

  • Succeeded in becoming one of the first 16 states in the nation to achieve and maintain full accreditation from the national Public Health Accreditation Board (PHAB).
  • Launched the State’s first Health Improvement Plan and multi-year agency strategic plans.
  • Significantly reduced infant mortality rates by nearly 30% from 2015 -2019 through close collaboration with many maternal and child health partners, and a 25% reduction in unintended pregnancies through the Delaware Contraceptives Access Now (Delaware CAN) initiative.
  • Saw a 14% reduction in cancer mortality rates through a comprehensive statewide prevention, screening, and treatment initiative.
  • Worked with the legislature to pass a bill increasing the age to buy tobacco products to 21 and adding e-cigarettes to Delaware’s Clean Indoor Air Act.
  • In conjunction with the University of Delaware and Delaware Community Foundation, spearheaded the creation of the Healthy Communities Delaware (HCD) initiative – a placed-based partnership with communities to address their most important social determinants of health.
  • Played the state’s leading role in responding to multiple health threats, including COVID-19, H1N1, Superstorm Sandy, Ebola, Zika virus, Tuberculosis outbreaks and others.
  • Launched the My Healthy Community data portal in 2019, bringing Delaware public health data down to the ZIP code level, including community characteristics, the environment, chronic disease, and mental health and substance use, air quality, asthma incidence data, public and private drinking water results, and drug overdose and death data. In 2020, when the COVID-19 pandemic began, the Division of Public Health used My Healthy Community to report COVID-19 data, again down to the ZIP code level in many cases. It was one of the most robust COVID-19 data sites in the country.
  • Assumed a leadership role in addressing the state’s opioid crisis.
  • Added the Medical Marijuana Program in 2014 to administer medical marijuana cards for eligible Delawareans and to license and oversee compassion centers in all three counties.
  • Added the Office of Animal Welfare in 2013 based on the recommendations of the General Assembly Animal Welfare Task Force as a way to consolidate and coordinate animal companion programs in Delaware

Dr. Rattay has earned multiple honors and awards. In 2019, she was awarded the prestigious Arthur T. McCormack Award by the Association of State and Territorial Health Officials (ASTHO) for her leadership and contributions as a state health official.  She also received the Vision of Peace award from the Delaware Coalition Against Domestic Violence; the Health Professional of the Year award from the National Alliance on Mental Illness; the President’s Award three times from former Medical Society of Delaware presidents; the Medal of Honor Award from atTAcK addiction and was honored by Governor Carney as the longest-serving state health official in the nation.

She has been named as one of “Delaware’s Most Influential” individuals for 2020 and 2021. Dr. Rattay chairs the Healthy Babies Subcommittee for ASTHO and is a Board member of ASTHO and the Public Health Foundation. She is the Chair of Delaware’s Addiction Action Committee, Co-Chair of the Overdose System of Care Committee, and a current member and former president of the Delaware Board of Medical Licensure and Discipline.

Dr. Rattay earned a Medical Doctorate from the Medical University of Ohio in 1992 and a Master of Science in Epidemiology from the University of Maryland in 2001. She completed her Pediatric Residency at Georgetown University and a Preventive Medicine and Public Health Residency training program at the University of Maryland.

Dr. Rattay is board-certified in pediatrics and practiced pediatrics for 14 years. Between September 2001 and June 2004, she served as a senior public health advisor to the U.S. Surgeon General and Assistant Secretary of Health in the Office of Disease Prevention and Health Promotion, Department of Health and Human Services, where she had a leadership role in the President’s Healthier U.S. Initiative. 

# # # 

 Anyone who is deaf, hard of hearing, Deaf-Blind or speech disabled can contact DPH by dialing 711 first using specialized devices (i.e., TTY, TeleBraille, voice devices). The 711 service is free and to learn more about how it works, please visit delawarerelay.com. 

 Delaware Health and Social Services is committed to improving the quality of the lives of Delaware’s citizens by promoting health and well-being, fostering self-sufficiency, and protecting vulnerable populations.


DPH Announces 22nd DEA National Prescription Drug Take-back Day For Delaware

DOVER (April 26, 2022) – Delaware will hold its 22nd National DEA Prescription Drug Take-Back Day on Saturday, April 30, 2022. Delawareans can discard their expired or unused medications at locations statewide between 10:00 a.m. and 2:00 p.m. There will also be Sharps disposals for needle disposal at select locations, and overdose response education with free Narcan available at select locations.

Organized nationally by the Drug Enforcement Administration (DEA), Prescription Drug Take-Back Day is operated locally by the Division of Public Health (DPH). The twice-a-year event is aimed at reducing the risk of prescription medications being diverted for misuse and has resulted in nearly 100,000 pounds of medication being collected since 2010. Properly discarding unused medications through this event is an important ongoing activity in the effort to address the nationwide opioid epidemic. Doing so reduces the risk of addiction by keeping prescription medications out of the hands of people who may misuse, abuse, or divert them, and helps reduce the risk of drug overdoses.

“The addiction for far too many people living with substance use first began because they had access to prescription medications from the homes of someone they know,” said DPH Director Dr. Karyl Rattay. “By safely turning in your prescription medications that have expired, or that you no longer need, on Drug Take-Back Day, you can help fight the epidemic in Delaware while also making your home safer.”

According to the 2020 National Survey on Drug Use and Health, 16.1 million people reported misusing any prescription drug in the past 12 months. The survey also showed that a majority of misused prescription drugs were obtained from family and friends, often from the home medicine cabinet. According to the state Division of Forensic Science, there were 515 overdose deaths in 2021 in Delaware, a 15 percent increase from the 447 reported in 2020.

In addition to the sites participating in National Prescription Drug Take-Back Day activities, there are 28 permanent medicine drop-off locations across the state available year-round. Six of Delaware’s permanent drop-off sites are in Walgreens pharmacies and the other 22 are located in local law enforcement agencies. In addition to medicine drop off locations, DPH and community partners also distribute medication deactivation bags to the public to use at home. For a list of permanent collection sites and how to get a free disposal bag, visit www.helpisherede.com/understanding-addiction/safe-drug-storage-and-disposal.

The medications to be disposed of at the Take-Back Day locations must be in a container such as a pill bottle, box, blister pack, or zipped plastic bag, with personal information removed. Liquid medications must be in their original containers. Besides medications, vape pens and e-cigarettes will be collected if the batteries are removed. There are 25 locations participating in the National Prescription Drug Take Back event. You can find the list of locations here: https://www.dea.gov/takebackday.

Delawareans can bring any used needles to be disposed of properly at the following locations (https://www.helpisherede.com/documents/DDPHOHCR-34668-HelpIsHereDE-SharpsDisposalLocations_R1.pdf). The used needle disposal containers are only for public and not commercial entities, and individuals will need to sign a waiver stating that needles are from home use. Outside of health care facilities, an estimated 7.8 billion injections occur a year according to solid waste and recycling organization Waste 360. Once recycled, needles can result in accidental sticks carrying blood-borne pathogens. The safest way to dispose of needles is to use a designated Sharps disposal container which is delivered to incinerators so that accidental exposure cannot occur.

To further enhance overdose prevention and education efforts, three of the DEA National Prescription Drug Take Back locations (Middletown, Wyoming, and Selbyville Police Departments) will also be offering Overdose Response Training and Narcan distribution to the public. It is recommended that anyone who has a prescription opioid or has friends and family who use opioid prescriptions or illicit drugs receive this training and the overdose reversal medication, Narcan. For other community trainings and where you can get free Narcan go to: https://www.helpisherede.com/overdose-prevention.

For more details about the National Prescription Drug Take-Back Day, visit http://dhss.delaware.gov/dph/hsp/hhdrugtakeback.html.

If you or a loved one is struggling with addiction in Delaware, call DHSS’ 24/7 Crisis Hotline to be connected to treatment and recovery options. In New Castle County, call 1-800-652-2929. Or in Kent and Sussex counties, call 1-800-345-6785. For free 24/7 counseling, coaching, and support, as well as links to mental health, addiction, and crisis services call the Delaware Hope Line at 833-9-HOPEDE. To search online for treatment and recovery services in Delaware or nearby states, visit HelpIsHereDE.com.

####

A person who is deaf, hard-of-hearing, deaf-blind or speech-disabled can call the DPH phone number above by using TTY services. Dial 7-1-1 or 800-232-5460 to type your conversation to a relay operator, who reads your conversation to a hearing person at DPH. The relay operator types the hearing person’s spoken words back to the TTY user. To learn more about TTY availability in Delaware, visit http://delawarerelay.com.


DPH Reports Increase In Covid-19 Cases, Hospitalizations; Rates Remain Low Compared To Winter Surge

DOVER, DE (April 22, 2022) – The Delaware Division of Public Health (DPH) is providing an update on case and vaccination data since the last COVID-19 update released on March 25, 2022.  While Delaware is experiencing a rise in COVID-19 cases and hospitalizations, both remain significantly lower than during the winter surge. Deaths are also low overall. Over the last month, DPH announced its first Test-to-Treat center in Newark, on April 14, 2022, and distributed approximately 190,000 over-the-counter (OTC) COVID-19 test kits to school districts, charter schools, and private/parochial schools.

DPH continues to encourage Delawareans to protect themselves and their families by using the tools they already have available to them to stay one step ahead of COVID-19:

  • Stay up to date with your vaccines. Get vaccinated and boosted when eligible. Vaccines are readily available. Find a vaccination site at de.gov/getmyvaccine
  • Stay home when you are sick.
  • Get tested if you have symptoms of COVID-19. Some symptoms mirror those of flu, which remains active in Delaware, and seasonal allergies.  Be sure. Find a testing location or where to get a home test kit at de.gov/gettested.
  • If you test positive for COVID, check with your health care provider to determine if you should get treatment for COVID-19.
  • Mask up in indoor public settings if you feel uncomfortable or unsafe, or have a weakened immune system, or if you live with someone who does. 

COVID-19 Cases and Hospitalizations:

  • Total positive cases since March 11, 2020: 261,118
  • 7-day average of new positive cases: 157.1, An increase of 94.0 average new positive cases from March 25, 2022.
  • 7-day average for the percentage of total positive tests: 7.6%, an increase of 4.4 percentage points from March 25, 2022.
  • Hospitalizations: 45 current hospitalizations (an increase of 10 since March 25); critically ill: 6, an increase of 4 since March 25, 2022.
  • Total COVID-19 deaths: 2,896 an increase of 59 since last month (2 regularly reported deaths; 57 deaths from a review of vital statistics).

COVID-19 Vaccinations:  

  • Total number of doses administered in Delaware: 1,757,355 
  • Percentage of Delawareans 5+ who are fully vaccinated (CDC data): 73% 
  • Percentage of Delawareans 12+ who are fully vaccinated (CDC data): 77.2%  
  • Percentage of Delawareans 18+ who are fully vaccinated (CDC data): 78.7% 
  • Percent of Delawareans who are fully vaccinated (CDC data): 68.9%  

Delaware’s latest COVID-19 vaccination statistics can be found under the Vaccine Tracker dashboard at de.gov/healthycommunity.  

COVID-19 Case Vaccination Status Report:  

The following reports capture a weekly breakdown of non-boosted cases, deaths, and hospitalizations for the time frame for April 11 – April 17, 2022. 

 

   

Weekly Overview
(4/11/22 – 4/17/22)

Non-boosted Cases

Total Non-boosted Cases

719

Total Cases

1094

Percent of Non-boosted Cases

66%

Non-boosted Hospitalized Cases

Total Non-boosted Hospitalized Cases

13

Total Hospitalized Cases

17

Percent of Non-boosted Cases

76%

Non-boosted Deaths

Total Non-boosted Deaths

0

Total COVID-19 Deaths

0

Percent of Non-boosted Deaths

N/A

Long-term Care Statistics:  

As of Thursday, April 21, 2022, there have been a total of 3,803 positive COVID-19 cases involving long-term care residents (an increase of 120 since March 25), and 945 residents of Delaware long-term care facilities have died from complications related to COVID-19 (an increase of 14).  

Flu Update: 

DPH reminds the public that flu season is not over.  There were 251 laboratory-confirmed cases reported the week of April 10-16, the most recent date for which flu statistics are available. There have been 1,708 laboratory-confirmed cases for the current season, an increase of 807 since March 25,2022. The cases involved 793 individuals from New Castle County, 371 from Kent County and 544 from Sussex County. This number reflects only the number of lab-confirmed cases; the actual number of cases circulating statewide is likely higher as not all people with the flu seek treatment, and many cases are diagnosed through rapid test kits in a provider’s office versus a lab. There may be technical discrepancies of reporting numbers week to week due to retroactive reporting of cases.  

In addition to staying home if you have flu-like symptoms, and taking antiviral medication as directed, DPH recommends that you:

  • Practice social distancing by keeping your distance from well people if you have cold or flu-like symptoms.
  • Wear a well-fitting face covering if you feel ill and have to go out in public to a doctor’s appointment or pharmacy.
  • Wash your hands frequently with soap and water or use alcohol-based hand sanitizers.
  • Cover coughs and sneezes with a tissue, and dispose of tissues immediately; if no tissue is available, cough or sneeze into your inner elbow.

Flu vaccines remain available at pharmacies (including those in grocery stores), participating medical provider offices, Federally Qualified Health Centers (for their patients), as well as Division of Public Health clinics.  For the latest information on the flu in Delaware, visit flu.delaware.gov

Resources:  

Individuals with general questions about COVID-19 should call Delaware 2-1-1, individuals who are deaf or hard of hearing can text their ZIP code to 898-211, or email delaware211@uwde.org. Hours of operation are:  

Monday – Friday: 8:00 a.m. to 9:00 p.m.  

Saturday: 9:00 a.m. to 5:00 p.m.  

Medically related questions regarding testing, symptoms, and health-related guidance can be submitted by email at DPHCall@delaware.gov.  

Delawareans 18 or older are encouraged to download COVID Alert DE, Delaware’s free exposure notification app to help protect your neighbors while ensuring your privacy. Download on the App Store or Google Play.  

DPH will continue to update the public as more information becomes available. For the latest on Delaware’s response, go to de.gov/coronavirus.    

### 

Anyone who is deaf, hard of hearing, Deaf-Blind or speech disabled can contact DPH by dialing 711 first using specialized devices (i.e., TTY, TeleBraille, voice devices). The 711 service is free and to learn more about how it works, please visit delawarerelay.com. 

The Delaware Department of Health and Social Services is committed to improving the quality of the lives of Delaware’s citizens by promoting health and well-being, fostering self-sufficiency, and protecting vulnerable populations.